Operating Income (Loss) in USD of Unity Biotechnology, Inc. from 2016 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Unity Biotechnology, Inc. quarterly/annual Operating Income (Loss) history and change rate from 2016 to Q1 2025.
  • Unity Biotechnology, Inc. Operating Income (Loss) for the quarter ending 31 Mar 2025 was -$6.89M, a 9.32% increase year-over-year.
  • Unity Biotechnology, Inc. Operating Income (Loss) for the twelve months ending 31 Mar 2025 was -$30.5M, a 27% increase year-over-year.
  • Unity Biotechnology, Inc. annual Operating Income (Loss) for 2024 was -$31.2M, a 30.2% increase from 2023.
  • Unity Biotechnology, Inc. annual Operating Income (Loss) for 2023 was -$44.7M, a 22.4% increase from 2022.
  • Unity Biotechnology, Inc. annual Operating Income (Loss) for 2022 was -$57.6M, a 1.6% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Unity Biotechnology, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$30.5M -$6.89M +$708K +9.32% 01 Jan 2025 31 Mar 2025 10-Q 22 Apr 2025
Q4 2024 -$31.2M -$9.99M -$2.31M -30.1% 01 Oct 2024 31 Dec 2024 10-K 07 Mar 2025
Q3 2024 -$28.9M -$6.6M +$7.98M +54.7% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2024
Q2 2024 -$36.8M -$6.98M +$4.87M +41.1% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2024
Q1 2024 -$41.7M -$7.6M +$2.96M +28% 01 Jan 2024 31 Mar 2024 10-Q 22 Apr 2025
Q4 2023 -$44.7M -$7.68M +$5.36M +41.1% 01 Oct 2023 31 Dec 2023 10-K 07 Mar 2025
Q3 2023 -$50M -$14.6M -$573K -4.09% 01 Jul 2023 30 Sep 2023 10-Q 04 Nov 2024
Q2 2023 -$49.5M -$11.8M +$410K +3.35% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024
Q1 2023 -$49.9M -$10.6M +$7.71M +42.2% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024
Q4 2022 -$57.6M -$13M -$3.14M -31.7% 01 Oct 2022 31 Dec 2022 10-K 07 Mar 2025
Q3 2022 -$54.4M -$14M +$820K +5.53% 01 Jul 2022 30 Sep 2022 10-K 15 Apr 2024
Q2 2022 -$55.3M -$12.3M +$4.74M +27.9% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023
Q1 2022 -$60M -$18.3M -$3.32M -22.2% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q4 2021 -$56.7M -$9.9M +$8.89M +47.3% 01 Oct 2021 31 Dec 2021 10-K 15 Apr 2024
Q3 2021 -$65.6M -$14.8M +$9.81M +39.8% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022
Q2 2021 -$75.4M -$17M +$6.35M +27.2% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022
Q1 2021 -$81.7M -$14.9M +$12.2M +45% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022
Q4 2020 -$93.9M -$18.8M +$4.31M +18.7% 01 Oct 2020 31 Dec 2020 10-K 23 Mar 2021
Q3 2020 -$98.2M -$24.6M -$2.29M -10.2% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 -$95.9M -$23.3M +$1.12M +4.58% 01 Apr 2020 30 Jun 2020 10-Q 10 Aug 2021
Q1 2020 -$97.1M -$27.2M -$7.42M -37.6% 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021
Q4 2019 -$89.7M -$23.1M -$282K -1.24% 01 Oct 2019 31 Dec 2019 10-K 23 Mar 2021
Q3 2019 -$89.4M -$22.4M -$2.98M -15.4% 01 Jul 2019 30 Sep 2019 10-K 23 Mar 2021
Q2 2019 -$86.4M -$24.5M -$3.67M -17.7% 01 Apr 2019 30 Jun 2019 10-K 23 Mar 2021
Q1 2019 -$82.7M -$19.7M -$3.26M -19.7% 01 Jan 2019 31 Mar 2019 10-K 23 Mar 2021
Q4 2018 -$79.5M -$22.8M -$10M -78.4% 01 Oct 2018 31 Dec 2018 10-K 11 Mar 2020
Q3 2018 -$69.4M -$19.4M -$7.29M -60.4% 01 Jul 2018 30 Sep 2018 10-K 11 Mar 2020
Q2 2018 -$62.2M -$20.8M -$9.1M -77.8% 01 Apr 2018 30 Jun 2018 10-K 11 Mar 2020
Q1 2018 -$53.1M -$16.5M -$7.44M -82.3% 01 Jan 2018 31 Mar 2018 10-K 11 Mar 2020
Q4 2017 -$45.6M -$12.8M 01 Oct 2017 31 Dec 2017 10-K 06 Mar 2019
Q3 2017 -$12.1M 01 Jul 2017 30 Sep 2017 10-K 06 Mar 2019
Q2 2017 -$11.7M 01 Apr 2017 30 Jun 2017 10-K 06 Mar 2019
Q1 2017 -$9.04M 01 Jan 2017 31 Mar 2017 10-K 06 Mar 2019

Unity Biotechnology, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$31.2M +$13.5M +30.2% 01 Jan 2024 31 Dec 2024 10-K 07 Mar 2025
2023 -$44.7M +$12.9M +22.4% 01 Jan 2023 31 Dec 2023 10-K 07 Mar 2025
2022 -$57.6M -$907K -1.6% 01 Jan 2022 31 Dec 2022 10-K 07 Mar 2025
2021 -$56.7M +$37.3M +39.7% 01 Jan 2021 31 Dec 2021 10-K 15 Apr 2024
2020 -$93.9M -$4.28M -4.77% 01 Jan 2020 31 Dec 2020 10-K 15 Mar 2023
2019 -$89.7M -$10.2M -12.8% 01 Jan 2019 31 Dec 2019 10-K 15 Mar 2022
2018 -$79.5M -$33.9M -74.2% 01 Jan 2018 31 Dec 2018 10-K 23 Mar 2021
2017 -$45.6M -$26.8M -142% 01 Jan 2017 31 Dec 2017 10-K 11 Mar 2020
2016 -$18.8M 01 Jan 2016 31 Dec 2016 10-K 06 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.